Enhancing the Therapeutic Window for Oligo Payloads in Cancer

By | 18 November 2025
  • Integrating saRNA and siRNA payloads into antibody conjugates
  • Managing immunogenicity and safety considerations
  • Identifying the next wave of oligonucleotide drug conjugate candidates